BALCHEM CORPBCPCEarnings & Financial Report
Balchem Corp is a global specialty chemicals and nutritional ingredients provider that develops, manufactures and distributes application-specific products for human nutrition, animal health, pharmaceutical and industrial end markets, serving customers across North America, Europe and Asia Pacific.
Revenue
$239.9M
Gross Profit
$85.4M
Operating Profit
$48.0M
Net Profit
$33.8M
Gross Margin
35.6%
Operating Margin
20.0%
Net Margin
14.1%
YoY Growth
4.3%
EPS
$1.03
BALCHEM CORP Q3 FY2024 Financial Summary
BALCHEM CORP reported revenue of $239.9M (up 4.3% YoY) for Q3 FY2024, with a net profit of $33.8M (up 16.4% YoY) (14.1% margin). Cost of goods sold was $154.6M, operating expenses totaled $37.4M.
Key Financial Metrics
| Total Revenue | $239.9M |
|---|---|
| Net Profit | $33.8M |
| Gross Margin | 35.6% |
| Operating Margin | 20.0% |
| Report Period | Q3 FY2024 |
Revenue Breakdown
BALCHEM CORP Q3 FY2024 revenue of $239.9M breaks down across 3 segments, led by Human Nutrition And Health at $152.3M (63.5% of total).
| Segment | Revenue | % of Total |
|---|---|---|
| Human Nutrition And Health | $152.3M | 63.5% |
| Animal Nutrition And Health | $52.9M | 22.0% |
| Specialty Products | $33.2M | 13.8% |
BALCHEM CORP Revenue by Segment — Quarterly Trend
BALCHEM CORP revenue by segment across the last 4 reported quarters, showing how each business line (such as Human Nutrition And Health and Animal Nutrition And Health) has evolved quarter over quarter.
| Segment | Q1 FY2026 | Q4 FY2025 | Q3 FY2025 | Q2 FY2025 |
|---|---|---|---|---|
| Human Nutrition And Health | — | $166.1M | $174.1M | $160.8M |
| Animal Nutrition And Health | — | $61.2M | $56.4M | $56.0M |
| Specialty Products | — | $34.8M | $35.7M | $37.2M |
BALCHEM CORP Annual Revenue by Year
BALCHEM CORP annual revenue history includes year-by-year totals (for example, 2025 revenue was $1.0B).
| Year | Annual Revenue |
|---|---|
| 2025 | $1.0B |
| 2024 | $953.7M |
| 2023 | $922.4M |
| 2022 | $942.4M |
BALCHEM CORP Quarterly Revenue & Net Profit History
BALCHEM CORP results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q1 FY2026 | $270.7M | +8.1% | $40.3M | 14.9% |
| Q4 FY2025 | $263.6M | +9.8% | $39.2M | 14.9% |
| Q3 FY2025 | $267.6M | +11.5% | $40.3M | 15.1% |
| Q2 FY2025 | $255.5M | +9.1% | $38.3M | 15.0% |
| Q1 FY2025 | $250.5M | +4.5% | $37.1M | 14.8% |
| Q4 FY2024 | $240.0M | +4.9% | $33.6M | 14.0% |
| Q3 FY2024 | $239.9M | +4.3% | $33.8M | 14.1% |
| Q2 FY2024 | $234.1M | +1.2% | $32.1M | 13.7% |
Income Statement
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $234.1M | $239.9M | $240.0M | $250.5M | $255.5M | $267.6M | $263.6M | $270.7M |
| YoY Growth | 1.2% | 4.3% | 4.9% | 4.5% | 9.1% | 11.5% | 9.8% | 8.1% |
Balance Sheet
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $1.57B | $1.60B | $1.58B | $1.62B | $1.68B | $1.66B | $1.69B | $1.69B |
| Liabilities | $462.6M | $419.7M | $425.5M | $408.9M | $410.3M | $363.2M | $428.8M | $408.6M |
| Equity | $1.11B | $1.18B | $1.15B | $1.21B | $1.27B | $1.30B | $1.26B | $1.29B |
Cash Flow
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $45.0M | $51.3M | $52.3M | $36.5M | $47.3M | $65.6M | $67.3M | $40.1M |